Verve Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Verve Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $-0.59 | $-0.70 | 15.7 % |
Jun 2024 | 2024-08-08 | $-0.59 | $-0.68 | 13.2 % |
Mar 2024 | 2024-05-08 | $-0.59 | $-0.71 | 16.9 % |
Dec 2023 | 2024-02-27 | $-0.69 | $-0.82 | 15.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $6.87M | $2.81M | 144.3 % |
Jun 2024 | 2024-08-08 | $6.69M | $2.40M | 178.8 % |
Mar 2024 | 2024-05-08 | $5.70M | $2.02M | 181.9 % |
Dec 2023 | 2024-02-27 | $5.14M | $1.17M | 339.6 % |
Verve Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3.
Verve Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was $-0.59, which beat the estimate of $-0.70.
Verve Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.